Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ · Healthcare
Black Diamond Therapeutics, Inc. Income Statement 2018–2025
| Dec 2025 | Dec 2024 | Dec 2020 | Dec 2019 | Dec 2018 | |
|---|---|---|---|---|---|
| Revenues | |||||
| Revenue | 70.0M | 0 | 0 | 0 | 0 |
| Gross Profit | — | — | — | — | — |
| Profitability | |||||
| Operating Income | 12.5M | -78.8M | -69.6M | -29.3M | -8.9M |
| EBITDA | — | — | — | — | — |
| Net Income | 22.4M | -69.7M | -67.3M | -35.3M | -8.9M |
| Per Share Data | |||||
| EPS (diluted) | — | — | — | — | — |
| Shares Outstanding (dil.) | 58M | 55M | 33M | 2M | 2M |
Black Diamond Therapeutics, Inc. Income Statement — FAQ
Black Diamond Therapeutics, Inc. (BDTX) income statement over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BDTX's income statement history?
The chart and table above show Black Diamond Therapeutics, Inc.'s income statement by year and by quarter, including the growth rate.